Category: Disease States

Disease States

New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.

Lunit has partnered with Microsoft to co-develop scalable, AI-powered healthcare solutions that enhance cancer detection.

Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.

Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.

A new AI-driven, non-DNA-based nanopore test can rapidly identify live viruses with high sensitivity by analyzing their unique signatures.

hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.

A new peer-reviewed study validates Vibrant Sciences’ microarray, enabling fast, accurate, scalable detection of over 17 tickborne pathogens.

University of Tokyo researchers have developed a non-invasive, AI-powered imaging system that tracks platelet activity in real time.

An FDA-cleared blood test that measures key Alzheimer’s disease biomarkers is a less invasive, more accurate method to diagnose the condition.

Two studies demonstrate how AI models can significantly improve early detection of type 1 diabetes, enabling earlier intervention.

A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis is a life-threatening emergency caused by the body's extreme response to infection, requiring rapid diagnosis and treatment.